AU2002321064A1 - Vitamin B6-phosphate phosphatase - Google Patents
Vitamin B6-phosphate phosphataseInfo
- Publication number
- AU2002321064A1 AU2002321064A1 AU2002321064A AU2002321064A AU2002321064A1 AU 2002321064 A1 AU2002321064 A1 AU 2002321064A1 AU 2002321064 A AU2002321064 A AU 2002321064A AU 2002321064 A AU2002321064 A AU 2002321064A AU 2002321064 A1 AU2002321064 A1 AU 2002321064A1
- Authority
- AU
- Australia
- Prior art keywords
- vitamin
- phosphate
- microorganism
- process according
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 title claims description 21
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 title claims description 21
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 title claims description 15
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 title claims description 15
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 title claims description 6
- 229960001327 pyridoxal phosphate Drugs 0.000 title 1
- 238000000034 method Methods 0.000 claims description 30
- 244000005700 microbiome Species 0.000 claims description 25
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 18
- 239000011726 vitamin B6 Substances 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- 239000011541 reaction mixture Substances 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 241000589196 Sinorhizobium meliloti Species 0.000 claims description 8
- 241001135312 Sinorhizobium Species 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- ZMJGSOSNSPKHNH-UHFFFAOYSA-N pyridoxamine 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(CN)=C1O ZMJGSOSNSPKHNH-UHFFFAOYSA-N 0.000 claims description 2
- 239000011580 pyridoxamine 5'-phosphate Substances 0.000 claims description 2
- 235000008974 pyridoxamine 5'-phosphate Nutrition 0.000 claims description 2
- WHOMFKWHIQZTHY-UHFFFAOYSA-L pyridoxine 5'-phosphate(2-) Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(CO)=C1O WHOMFKWHIQZTHY-UHFFFAOYSA-L 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 description 34
- 108090000790 Enzymes Proteins 0.000 description 34
- 229940088598 enzyme Drugs 0.000 description 34
- 239000000872 buffer Substances 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 14
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 12
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 12
- 235000011130 ammonium sulphate Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920002684 Sepharose Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000001952 enzyme assay Methods 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102100033468 Lysozyme C Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 239000012506 Sephacryl® Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 239000011677 pyridoxine Substances 0.000 description 3
- 235000008160 pyridoxine Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910017621 MgSO4-7H2O Inorganic materials 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000589166 Sinorhizobium fredii Species 0.000 description 1
- 241001509304 Sinorhizobium saheli Species 0.000 description 1
- 241000143663 Sinorhizobium terangae Species 0.000 description 1
- 241001135313 Sinorhizobium xinjiangense Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- COSZWAUYIUYQBS-UHFFFAOYSA-B hexapotassium hexasodium 3-carboxy-3-hydroxypentanedioate 2-hydroxypropane-1,2,3-tricarboxylate hydrate Chemical compound O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[K+].[K+].[K+].[K+].[K+].[K+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O COSZWAUYIUYQBS-UHFFFAOYSA-B 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- POSZUTFLHGNLHX-KSBRXOFISA-N tris maleate Chemical compound OCC(N)(CO)CO.OCC(N)(CO)CO.OC(=O)\C=C/C(O)=O POSZUTFLHGNLHX-KSBRXOFISA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Description
VITAMIN B^-PHOSPHATE PHOSPHATASE
The present invention relates to a novel enzyme, namely vitamin B6-phosphate phosphat- ase (hereinafter referred to as VB6PP), a process for producing VB6PP and a process for producing vitamin B6 from vitamin B6-phosphate (hereinafter referred to as VB6P) utilizing VB6PP and a cell-free extract of a specific microorganism capable of producing VB6PP.
"Vitamin B6" as used in the present invention includes pyridoxol, pyridoxal and pyridox- amine. Vitamin B6 is one of the important vitamins for the nutrition of human, animals, plants and microorganisms.
It is well-known that nonspecific phosphomonoesterases such as alkaline and acid phos- phatases hydrolyze various kinds of phosphoric acid-monoester compounds including VB6P to the corresponding ester-free compounds [Glenn and Dilworth, Arch. Microbiol. 126:251-256 (1980)]. There is no report on VB6P-specific phosphatase except for a phos- phatase purified from human erythrocytes [Fonda, J. Biol. Chem. 267:15978-15983 (1992)].
It is an object of the present invention to provide the novel VB6PP which acts on VB6P to produce vitamin B6. The VB6PP of the present invention has the following physico-chemical properties: a) Molecular weight: 29,000 ± 5,000 (consisting of a monomer having a molecular weight of 29,000 ± 5,000) b) Co-factor: Mn2+, Mg2+, Co2+, Sn2+ or Ni2+ c) Substrate specificity: active on pyridoxol 5'-phosphate (hereafter referred to as PNP), pyridoxal 5'-phosphate (hereafter referred to as PLP) and pyridoxamine 5'-phosphate (hereafter referred to as PMP) d) Optimum temperature: 30-40°C at pH 7.5 e) Optimum pH: 7.0-8.0.
It is another object of the present invention to provide a process for producing the novel VB6PP as defined above, which comprises cultivating a microorganism belonging to the genus Sinorhizobium which is capable of producing the VB6PP having the above physico- chemical properties, in an aqueous nutrient medium under aerobic conditions, disrupting cells of the microorganism and isolating and purifying the VB6PP from the cell-free extract of the disrupted cells of the microorganism.
A still further object of the present invention is to provide a process for producing vitamin B6 from VB6P which comprises contacting VB6P with (i) the VB6PP as defined above in the presence of Mn2+, Mg2+, Co2+, Sn2+ or Ni2+, or (ii) a cell-free extract of said micro- organism belonging to the genus Sinorhizobium which is capable of producing the VB6PP having the above physico-chemical properties, and in each of the cases (i) and (ii) isolating the resulting vitamin B6 from the reaction mixture.
The physico-chemical properties of the purified sample of the VB6PP prepared according to the Examples hereinafter are as follows:
1) Enzyme activity
The novel VB6PP of the present invention catalyzes hydrolysis of VB6P to vitamin B6 in the presence of a divalent metal ion i.e. Mn2+, Mg2+, Co2+, Sn2+ or Ni2+ according to the following formula:
VB6P + H20 → vitamin B6 + H3PO4
The standard enzyme assay was performed as follows: The basal reaction mixture of total volume 125 μl and consisting of 50 mM Tris-HCl buffer (pH 7.5), 1 mM MnCl2, 1.35 μg of enzyme and water up to a total volume of 118.5 μl, and was incubated for 1 minute at 37°C. Then 6.5 μl of 800 μM PNP solution was added to give a final concentration of 40 μM, and the whole was incubated at 37°C. After incubation for 30 minutes, the reaction mixture was cooled down into an ice bath. Activity was determined in the following two ways, (i) Produced vitamin B6 was microbiologically measured by the turbidity method with Saccharomyces carlsbergensis ATCC 9080 according to the method of Osbone and Voogt [The Analysis of Nutrients in Foods, Academic Press, London, 224-227 (1978)]. One unit of the enzyme activity was defined as-the amount of enzyme synthesizing 1 μmole of vitamin B6 for 30 minutes in the assay system described above, (ii) Phosphate released from putative substrates was colorimetrically measured by the malachite green method of Geladopoulos et al. [Analytical Biochemistry 192:112-116 (1991)] and this
method was used for determination of substrate specificity and michaelis constant (Km) and maximum velocity (Vmax) values.
The protein concentration was determined by the Lowry method [Lowry et al., J. Biol. Chem. 193:265-275 (1951)].
2) Molecular weight
The molecular weight (hereinafter referred to as MW) of the enzyme was measured with a gel filtration column HiPrep Sephacryl S-200HR (Amersham Pharmacia Biotech (Uppsala, Sweden). The apparent MW of the enzyme was calculated to be 29,000 ± 5,000 in comparison with the MW marker proteins: Gel filtration Standard kit, Bio-Rad Laboratories (Bio-Lad Laboratories, Richmond, California, USA); thyroglobulin (MW 670,000), bovine gamma globulin (MW 158,000), chicken ovalbumin (MW 44,000), equine myoglobin (MW 17,000) and vitamin B[2 (MW 1,350). SDS-Polyacrylamide gel electrophoresis (hereinafter referred to as SDS-PAGE) gave a single band with a MW of 29,000 ± 5,000 in comparison with the molecular marker proteins: Low MW Electrophoresis calibration kit (Amersham Pharmacia Biotech, Uppsala, Sweden); bovine serum albumin (MW 67,000), ovalbumin (MW 43,000), carbonic anhydrase (MW 30,000), soybean trypsin inhibitor (MW 20,100) and α-lactalbumin (MW 14,400). This indicates that the enzyme is composed of a monomer unit. The values of the MW of the enzyme (MW 29,000 ± 5,000) were determined as accurately as the respective methods, i.e. the gel filtration column method and the SDS-PAGE method, allowed.
3) Co-factor
The co-factor requirement of the enzyme to convert VB6P to vitamin B6 was investigated. As a result, it was established that a divalent metal ion i.e. Mn2+, Mg2+, Co2+, Sn2+ or Ni2+ could serve as a co-factor for this conversion.
Table 1
4) Substrate specificity
The substrate specificity of the enzyme was determined using the same method as described under 1), except for various substrate solutions (160 μM, final concentration in the reaction mixture) were used. Table 2
5) Optimum temperature
The enzyme activities were measured at temperatures from 5 to 45°C. The optimum temperature of the enzyme activity was 30-40°C. Table 3
6) Optimum pH
The correlation between the enzyme activity and the pH values of the reaction mixture was determined by using the same enzyme assay method as described under 1). The optimum pH of the enzyme reaction was found to be 7.0-8.0.
Table 4
7) Temperature stability
The enzyme solution was treated at various temperatures for 10 minutes, and the remaining enzyme activities were measured by using the same enzyme assay method as described under 1). It was established that the enzyme activity was decreased with increasing temperature, becoming completely inactivated at 50°C.
Table 5
7) Michaelis constant (Km) and Maximum velocity (Vmax) values
The Km value of the enzyme was measured by using PNP and PLP as the substrates. The basic enzyme assay method is the same as described under 1), but the substrate concentration was varied. The Km and Vmax values against PNP were 330 μM and 92 nmol/min/mg, respectively. On the other hand, the Km and Vmax values against PLP were 1.22 mM and 46 nmol/min/mg, respectively.
The Km and Vmax values were calculated on the basis of the known Michaelis-Menten equation. Km is the concentration of the substrate that gives 50% of the Vmax of the enzyme reaction. The values give a useful indication of the catalytic properties of the enzyme for the involved substrate.
8) Purification procedure
The purification of the VB6PP may in principle be effected by any combination of known purification methods, such as fractionation with precipitants, e.g. ammonium sulfate, polyethylene glycol and the like, ion exchange chromatography, adsorption chromatography, hydrophobic interaction chromatography, gel- filtration chromatography, gel electrophoresis and salting out and dialysis.
As mentioned above, the VB6PP by present invention can be prepared of the cultivating an appropriate microorganism in an aqueous nutrient medium under aerobic conditions, disrupting the microorganism and isolating and purifying the VB6PP from the cell-extract of the disrupted cells of the microorganism.
The microorganisms used for the present invention are microorganisms belonging to the genus Sinorhizobium which are capable of producing vitamin B6 as defined hereinbefore. And the microorganisms which can be used in the present invention include S. meliloti, S. fredii, S. xinjiangense, S. saheli, S. terangae and . medicae. Mutants of said micro- organism can also be used in the present invention.
A preferred strain is Sinorhizobium meliloti. The specific strain most preferably used in the present invention is deposited at the Institute for Fermentation, Osaka, 17-85, Juso-hon- machi 2-chome, Yodogawa-ku Osaka 523-8686 Japan as Sinorhizobium meliloti IFO 14782, and also deposited at the DSM, Deutsche Sammlung Von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg lb, D-3300 Braunschweig, Germany as DSM No. 10226 under the Budapest Treaty.
The microorganism may be cultured in a nutrient medium containing saccharides such as glucose and sucrose, alcohols such as ethanol and glycerol, fatty acids such as oleic acid
and stearic acid, or esters thereof, or oils such as rapeseed oil and soybean oil as carbon sources; urea, ammonium sulfate, ammonium chloride, sodium nitrate, peptone, amino acids, corn steep liquor, bran, yeast extract and the like as nitrogen sources; magnesium sulfate, manganese sulfate, iron sulfate, sodium chloride, calcium carbonate, potassium monohydrogen phosphate, potassium dihydrogen phosphate and the like as inorganic salt sources; and malt extract, meat extract and the like as other nutrient sources. The pH of the culture medium may be from about 5 to 9, preferably from about 6 to about 8. The temperature range for the cultivation is suitably from about 10°C to about 45°C, preferably from about 25°C to about 40°C. The cultivation time is normally from about 1 to about 5 days, preferably about 1 to about 3 days. Aeration and agitation during the cultivation usually give favorable results.
An embodiment for isolation and purification of the VB6PP from the microorganism after the cultivation is as follows:
Cells are harvested from the liquid culture by centrifugation or filtration. The harvested cells are washed with water, physiological saline or a buffer solution having an appropriate pH.
The washed cells are pretreated in a buffer containing EDTA/lysozyme and disrupted by means of a homogenizer, sonicator, French press and the like to give a solution of disrupted cells. The VB6PP is isolated and purified from the cell-free extract of disrupted cells.
The VB6PP provided by the present invention is useful as a catalyst for the production of vitamin B6 from VB6P.
The reaction of the VB6PP-catalyzed hydrolysis of VB6P to vitamin B6 is conveniently conducted at pH values from about 5.5 to about 9.0 for 15 minutes to 5 hours in the presence of a divalent metal in a solvent. A more preferable pH range is from of about 6.5 to about 8.0. As a solvent, any buffer which maintains the pH in the range of about 5.5 to about 9.5 such as Tris-HCl buffer, Tris-maleate buffer, Bis-tris buffer, HEPES (Dojindo Laboratories, Kumamoto prefecture, Japan) buffer and the like, is suitable.
A preferred pH range of carrying out the reaction is from about 15°C to about 45°C, and a more preferable temperature range is from of about 25°C to about 40°C. The reaction usually gives the best result when the pH and the temperature are set at about 6.5 to about 8.0 and about 37°C.
The concentration of VB6P in the solvent depends on the other reaction conditions, but in general is from 1 μM to 1 M, preferably from 10 μM to 100 mM.
The amount of a divalent metal suitably present in the reaction mixture depends on the other reaction conditions, but in general is in each case independently about 1 μM to 100 mM.
In the reaction, the VB6PP may also be used in an immobilized state with an appropriate carrier. Any means of immobilizing enzymes generally known in the art may be used. For instance, the enzyme may be bound directly to a membrane, granules or the like of a resin having one or more functional groups, or it may be bound to the resin through bridging compounds having one or more functional groups, e.g. glutaraldehyde. Such enzyme immobilizing means are described for example on pages 369-394 of the 2n Edition of Micro- bial Enzymes and Biotechnology, Elsevier Applied Science (1990); Ed. Fogarty and Kelly).
The following Examples further illustrate the present invention.
Example 1: Preparation of VB6PP
All the operations were performed at 4°C, and the buffer was 10 mM Tris-HCl buffer
(pH 7.5) containing 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride and 15% sucrose unless otherwise stated.
(1) Cultivation of Sinorhizobium meliloti IFO 14782 (DSM No. 10226): The microorganisms were cultured in a seed medium containing 1% glucose, 0.5% polypeptone (Nihon Pharmaceutical Co., Osaka, Japan), 0.2% yeast extract (Difco Laboratories, Detroit, Michigan, USA), 0.05% MgSO4-7H2O, 0.001% MnSO4-5H20 and 0.001% FeSO4-7H20 at 28°C for 17 hours. The seed culture was transferred into a 500 ml flask containing 200 ml of a fermentation medium including 4% glucose, 2% polypeptone, 0.2% yeast extract, 0.05% MgS04-7H2O, 0.05% MnSO4-5H20, 0.001% FeSO4-7H20 and one drop of antifoam CA- 115 (Nippon Yushi Co., Ltd., Tokyo, Japan). The flask was shaken on a flask shaker at 28°C. After cultivation for 72 hours, 59.5 g of wet cells was obtained from 3.4 liters of the culture broth by centrifugation at 10,400 x g for 10 minutes.
(2) Treatment of EDTA-lysozyme: Lysozyme/EDTA treatment was performed to remove the periplasmic fraction of the cells according to the method of Glenn et al. [J. Gen. Micro- biol. 112:405-409 (1979)]. The wet cells (59.5 g) were suspended in 340 ml of 30 mM Tris- HCl buffer (pH 8.0) containing 20% sucrose and 1 mM EDTA. 170 mg of lysozyme
(Sigma Chemical Co., St. Louis, Missouri, USA) was added to the suspension stirring at room temperature, and then the stir was continued for 20 minutes. The cells were recovered by centrifugation at 10,400 x g for 10 minutes.
(3) Preparation of the cell-free extract: The cells were suspended in 340 ml of the buffer, and passed through a French pressure cell at 800 kg/cm2. After the treatment, the homo- genate was centrifuged at 34,000 x g for 90 minutes. As a result, 280 ml of cell-free extract containing 8,570 mg of proteins was obtained.
(4) Q Sepharose HP chromatography: The cell-free extract (280 ml) obtained in the previous step was applied to a Q Sepharose HP column (44 mm in diameter and 17 cm in height; Amersham Pharmacia Biotech, Uppsala, Sweden) which was equilibrated with the buffer. After washing with the column with the same buffer, the enzyme was eluted at the concentration of 0.4 M KC1. The active fractions (350 ml) were collected and dialyzed overnight against 4 liters of the buffer.
(5) Q Sepharose HP rechromatography: The dialyzed sample (5,700 mg protein) obtained in the previous step was rechromatographed with a Q Sepharose HP column (44 mm in diameter and 12.5 cm in height) which was equilibrated the buffer. After washing with the column with the same buffer, the enzyme was eluted at the concentration of 0.25 M KC1 with a linear gradient of KC1 (0-0.5 M). The active fractions were collected and dialyzed overnight against 4 liters of the buffer.
(6) Ether Toyopearl chromatography: To the dialyzed enzyme solution (316 mg protein) obtained in the previous step was added ammonium sulfate to give a concentration of 1.3 M. Then the resultant sample was applied to a Ether Toyopearl column (2.5 cm in diameter and 15 cm in height; Tosoh Co., Tokyo, Japan) which was equilibrated with the buffer containing 1.3 M ammonium sulfate. After washing the buffer containing 1.3 M ammonium sulfate, the enzyme was eluted at the concentration of 0.86 M ammonium sulfate with a linear gradient of ammonium sulfate (1.3-0.5 M). The active fractions were collected.
(7) Resource ISO chromatography: To the active enzyme solution (74 mg protein) obtained in the previous step was added ammonium sulfate to give a concentration of 1.2 M. Then the active enzyme solution was applied to a Resource ISO 6 ml column (Amersham Pharmacia Biotech, Uppsala, Sweden) which was equilibrated with the buffer containing 1.2 M ammonium sulfate. After washing the buffer with 1.2 M ammonium sulfate, the enzyme was eluted at the concentration of 0.74 M ammonium sulfate with a linear gra-
dient of ammonium sulfate (1.2-0.5 M). The active fractions were collected and dialyzed overnight against 4 liters of the buffer.
(8) HiPrep 16/60 Sephacryl S-200HR column: The dialyzed sample from previous step was concentrated by ultrafiltration (Centriplus YM-10 and followed by Microcon YM-10 concentrators, Amicon Inc., Beverly, Massachusetts, USA) to 300 μl. The sample (4.2 mg protein) was applied to a HiPrep 16/60 Sephacryl S-200HR column (16 mm in diameter and 60 cm in height; Amersham Pharmacia Biotech, Uppsala, Sweden) which was equilibrated by 50 mM Tris-HCl (pH 7.5) containing 15% sucrose, 1 mM DTT and 150 mM KC1. The enzyme was eluted with 70.5 ml of the buffer. This enzyme gave a homogenous band on SDS-PAGE analyses.
Table 6: Summary of the purification steps of the enzyme
(9) Identification of the reaction product: The reaction mixture of total volume 5 ml consisting of 50 mM Tris-HCl buffer (pH 7.5), 640 μM PNP, 1 mM MnCl2 and 108 μg of the enzyme was incubated at 37°C. After incubation for 1 hour, the reaction mixture was boiled for 3 minutes in a water bath and the resultant denaturated proteins in the reaction mixture were removed by centrifugation. The supernatant was applied on a Amberlite CG-120 (Rohm and Haas Company, Philadelphia, Pennsylvania, USA) column (16 mm in diameter and 11 cm in length). The column was washed with 40 ml of water and developed by 5% ammonium solution. Fractions eluted with the ammonium solution were pooled, concentrated under reduced pressure. The residue was dissolved in a small amount of methanol, and then analyzed on high pressure liquid chromatography under analytical conditions as follows: column, a Capcell pak s SGI 20 column (4.6 mm in diameter and 250 mm in height, Shiseido Co., Tokyo, Japan); mobile phase, 0.1M sodium perchlorate, 0.1M potassium phosphate and 2% acetonitrile (pH 3.5); flow rate, 1
ml/minute; a UV detector set at 292 nm. As a result, the sample was identified as being pyridoxol in comparison with a standard sample of pyridoxol.
Claims (15)
1. A vitamin e phosphate-phosphatase having the following physico-chemical properties: a) Molecular weight: 29,000 ± 5,000 (consisting of a monomer having a molecular weight of 29,000 ± 5,000) b) Co-factor: Mn2+, Mg2+, Co2\ Sn2+ or Ni2+ c) Substrate specificity: active on pyridoxol 5'-phosphate, pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate d) Optimum temperature: 30-40°C at pH 7.5 e) Optimum pH: 7.0-8.0
2. The vitamin B6-phosphate phosphatase according to claim 1, which is obtained from a microorganism belonging to the genus Sinorhizobium which microorganism is capable of producing said vitamin B6-phosphate phosphatase.
3. The vitamin B6-phosphate phosphatase according to claim 2, wherein the microorganism is Sinorhizobium meliloti IFO 14782 (DSM No. 10226) or a mutant thereof.
4. A process for producing a vitamin B6-phosphate phosphatase according to claim 1, which comprises cultivating a microorganism belonging to the genus Sinorhizobium which is capable of producing a vitamin B6-phosphate phosphatase having the above mentioned physico-chemical properties, in an aqueous nutrient medium under aerobic conditions, disrupting cells of the microorganism and isolating and purifying the vitamin B6-phos- phate phosphatase from the cell-free extract of the disrupted cells of the microorganism.
5. The process according to claim 4, wherein the microorganism is Sinorhizobium meliloti IFO 14782 (DSM No. 10226) or a mutant thereof.
6. The process according to claim 4, wherein the fermentation is effected in a pH range from 5.0 to 9.0 , and in a temperature range from 10°C to 45 °C for 1 day to 5 days.
7. The process according to claim 4, wherein the fermentation is effected in a pH range from 6.0 to 8.0 , and in a temperature range from 25°C to 40 °C for 1 day to 3 days.
8. A process for producing vitamin B6 from vitamin B6 phosphate which comprises contacting vitamin B6 phosphate with a vitamin B6-phosphate phosphatase according to claim 1 in the presence of Mn2+, Mg2+, Co2+, Sn2+ or Ni2+ and isolating the resulting vitamin B6 from the reaction mixture.
9. The process according to claim 8, wherein the vitamin B6-phosphate phosphatase is obtained from Sinorhizobium meliloti IFO 14782 (DSM No. 10226) or its mutant.
10. The process according to claims 8 to 9, wherein the reaction is effected in a pH range from 5.5 to 9.0, and in a temperature range from 15°C to 45 °C for 15 minutes to 5 hours.
11. The process according to claims 8 to 10, wherein the reaction is effected in a pH range from 6.5 to 8.0, and in a temperature range from 25°C to 40°C for 30 minutes to 3 hours.
12. A process for producing vitamin B6 from vitamin B6 phosphate which comprises contacting vitamin B6 phosphate with a cell-free extract of a microorganism belonging to the genus Sinorhizobium which is capable of producing the vitamin B6-phosphate phosphatase according to claim 1, and isolating the resulting vitamin B6 from the reaction mixture.
13. The process according to claim 12, wherein the microorganism is Sinorhizobium meliloti IFO 14782 (DSM No. 10226) or a mutant thereof.
14. The process according to claim 12, wherein the reaction is effected in a pH range from 5.5 to 9.0, and in a temperature range from 15°C to 45 °C for 15 minutes to 5 hours.
15. The process according to claim 12, wherein the reaction is effected in a pH range from 6.5 to 8.0, and in a temperature range from 25°C to 40°C for 30 minutes to 3 hours.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01114915.0 | 2001-06-20 | ||
| EP01114915 | 2001-06-20 | ||
| PCT/EP2002/006625 WO2003000875A2 (en) | 2001-06-20 | 2002-06-14 | Vitamin b6-phosphate phosphatase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002321064A1 true AU2002321064A1 (en) | 2003-06-19 |
| AU2002321064B2 AU2002321064B2 (en) | 2007-11-29 |
Family
ID=8177764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002321064A Expired - Fee Related AU2002321064B2 (en) | 2001-06-20 | 2002-06-14 | Vitamin B6-phosphate phosphatase |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6984510B2 (en) |
| EP (1) | EP1397487B1 (en) |
| JP (1) | JP4085055B2 (en) |
| KR (1) | KR20040004718A (en) |
| CN (2) | CN101386843A (en) |
| AT (1) | ATE388225T1 (en) |
| AU (1) | AU2002321064B2 (en) |
| CA (1) | CA2449378A1 (en) |
| DE (1) | DE60225444T2 (en) |
| WO (1) | WO2003000875A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2297228T3 (en) * | 2002-09-27 | 2008-05-01 | Dsm Ip Assets B.V. | A GEN THAT CODIFIES FOR VITAMIN B6-PHOSPHATE-PHOSPHATASE AND ITS USE. |
| DE10326750B4 (en) * | 2003-06-13 | 2006-07-27 | Gerlach, Jörg, Dr.med. | Process for the preparation of a cell preparation and cell preparations prepared in this way |
| DE10326746B4 (en) * | 2003-06-13 | 2006-04-06 | Gerlach, Jörg, Dr.med. | Bioreactor in the form of organ copy, process for its preparation and its use for the cultivation, differentiation, preservation and / or use of cells |
| JP5354490B2 (en) * | 2006-09-01 | 2013-11-27 | 興和株式会社 | Novel microorganism with diphenylarsinic acid resolution |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766894A (en) * | 1995-09-30 | 1998-06-16 | Roche Vitamins Inc. | Production of vitamin B6 by fermentation |
| ID22473A (en) * | 1998-04-15 | 1999-10-21 | Hoffmann La Roche | VITAMIN ENZIMATIC PRODUCTION B6 |
| EP0950715A3 (en) * | 1998-04-15 | 2001-07-25 | F. Hoffmann-La Roche Ag | Enzymatic production of vitamin B6 |
-
2002
- 2002-06-14 DE DE60225444T patent/DE60225444T2/en not_active Expired - Lifetime
- 2002-06-14 US US10/481,099 patent/US6984510B2/en not_active Expired - Fee Related
- 2002-06-14 KR KR10-2003-7016612A patent/KR20040004718A/en not_active Ceased
- 2002-06-14 EP EP02754686A patent/EP1397487B1/en not_active Expired - Lifetime
- 2002-06-14 CA CA002449378A patent/CA2449378A1/en not_active Abandoned
- 2002-06-14 WO PCT/EP2002/006625 patent/WO2003000875A2/en not_active Ceased
- 2002-06-14 JP JP2003507260A patent/JP4085055B2/en not_active Expired - Fee Related
- 2002-06-14 CN CNA2008101320016A patent/CN101386843A/en active Pending
- 2002-06-14 AT AT02754686T patent/ATE388225T1/en not_active IP Right Cessation
- 2002-06-14 CN CN028125533A patent/CN1518594B/en not_active Expired - Fee Related
- 2002-06-14 AU AU2002321064A patent/AU2002321064B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0922759A2 (en) | Aldehyde dehydrogenase | |
| AU2002321064B2 (en) | Vitamin B6-phosphate phosphatase | |
| AU2002321064A1 (en) | Vitamin B6-phosphate phosphatase | |
| EP0911415B1 (en) | Microbiological manufacture of L-ascorbic acid | |
| US4904593A (en) | Novel microorganism, a novel esterase and method for preparing the same | |
| EP0790301B1 (en) | Aldehyde Dehydrogenase | |
| AU616450B2 (en) | A process for the enzymatic hydrolysis of alpha- aminoadipinyl-monoamino compounds | |
| US7202068B2 (en) | Enone reductase and methods of making and using thereof | |
| JP4236323B2 (en) | Novel esterolytic enzyme | |
| US5238816A (en) | Omega carboxyalcohol oxidase enzyme | |
| US6465228B1 (en) | Levodione reductase | |
| JPH07108219B2 (en) | Method for producing NADH oxidase | |
| JPH11253157A (en) | Microbe having ability for producing new lipase, lipase, its production and its use | |
| JP3729946B2 (en) | Alcohol oxidase and method for producing aldehydes using the same | |
| JPH0239237B2 (en) | SHUSANOKISHIDAAZENOSEIZOHO | |
| EP0135166A1 (en) | Process for producing dihydroxyacetone kinase | |
| JPH0787781B2 (en) | Phospholipase D and method for producing phospholipase D | |
| GB2088384A (en) | Aryl Acylamidase | |
| JPH1156356A (en) | Lactone hydrolase and its production |